Clo­vis On­col­o­gy her­alds a PARP vic­to­ry in front­line ovar­i­an can­cer — does any­one re­al­ly care much?

Ear­ly on Thurs­day, Clo­vis On­col­o­gy trum­pet­ed pos­i­tive Phase III da­ta for their PARP play­er Rubra­ca in front­line main­te­nance care of ovar­i­an can­cer, out­lin­ing a much …

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE LOG IN